四方光电战略投资畅合生物

Core Viewpoint - Sifang Optoelectronics has signed a strategic investment agreement with Suzhou Changhe Biotechnology, acquiring a 57.14% stake in the company, aiming to expand into the high-end bio-safety detection instrument sector [1] Group 1: Strategic Investment - The investment was made using Sifang Optoelectronics' own funds through the transfer of equity and capital increase [1] - This strategic integration will allow both companies to deeply merge in product technology development, operational production, and sales channels [1] Group 2: Market Expansion - Sifang Optoelectronics plans to leverage its core component advantages in the sensor field to develop low-cost bio-safety sensors [1] - The new bio-safety sensors are intended for mass application in household appliances, automobiles, and buildings [1]